DMT Archives

Psychedelics News

DMT

Industry

3 Oct 2023

atai Life Sciences Completes Phase 1 Study of Oral DMT

Atai Life Sciences has completed its Phase 1 study of VLS-01, an oral DMT for treatment-resistant depression (TRD)....

By Jason Najum

Industry

8 Aug 2023

Algernon NeuroScience Announces Phase 2 DMT Stroke Study

Algernon NeuroScience has completed a feasibility study and has finalized its clinical trial design for a 40 patient Phase 2 DMT Stroke study....

By Microdose NewsDesk

Industry

24 May 2023

Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial

Cybin announced the first participants have been dosed with CYB004 in its three-part Phase 1 clinical trial...

By Microdose NewsDesk

Industry

5 Apr 2023

Small Pharma Announces Positive 6-month Data from Phase 2a DMT Trial

Small Pharma releases additional data from its Phase 2 trial — nearly 2/3 of patients remained in remission after 6 months....

By James Hallifax

Join Our Newsletter for Exclusive Updates, Stories, and More

Science

21 Mar 2023

New Study Gives Most Advanced View of the Brain on Psychedelics

A new study looking at DMT effects on the brain has produced the most detailed view yet of psychedelics and DMT's powerful potential....

By Microdose NewsDesk

Industry

27 Dec 2022

2022 End of Year Review: Small Pharma

Continuing our end-of-year review, we’ll take a moment to update DMT company Small Pharma’s last 12 months....

By Microdose NewsDesk

Science

1 Nov 2022

Decoding the Difference Between 5-MeO-DMT and N, N-DMT

While there are similarities between the two compounds, it’s important to understand that N, N-DMT and 5-MeO-DMT have significantly different effects and possible potential....

By Patrick McConnell

Industry

7 Oct 2022

atai Life Sciences Doses First Patient in New DMT Clinical Trial

On Wednesday, atai published a press release celebrating the first patient being dosed in their Phase 1 DMT safety trial....

By James Hallifax

Industry, Science

22 Jun 2022

New DMT Study Shows Positive Results for Depression

A new study published in Nature has a variety of interesting results for the use of DMT, showing positive results for depression and potential for easier patient access....

By Jason Najum

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result